Yamada, Akira <br/><br/>
Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24, -A31 and -A33)-positive patients with advanced cancer.  [electronic resource] 

 -  Experimental and therapeutic medicine  Jan 2011 
 - 109-117 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1792-0981 
<br/><br/><label>Standard No.: </label>10.3892/etm.2010.177  doi